“Europe is at the forefront of microbiome and synthetic biology research and it is vital to find innovative new investment approaches to support the next wave of life science entrepreneurs. Through eureKARE’s pioneering approach, we are poised to identify, select and nurture the very best European science to create exciting new companies with the potential to disrupt and revolutionize the life sciences industry for the benefit of patients, while delivering shareholder value.”
Alexandre Mouradian, Founder & Chairman
eureKAWARDS: the new pitch contest in synthetic biology
eureKAWARDS is a science-based pitch contest aimed at discovering and supporting ambitious synthetic biology projects from across Europe.
You are a researcher working on a fantastic synthetic biology project in your university lab, biohacking space or personal garage and looking to get a well-deserved head start?
eureKAWARDS is exactly what you need: a great opportunity to present your idea, concept or even your pre-startup plan in front of our panel of renowned scientific experts and business partners to compete for a full year of free access to eureKARE’s synthetic biology studio, eureKASYNBIO
A disruptive approach
led by an international team of experts
eureKARE is guided by its influential founders, Alan Howard, a renowned international fund manager, and think-tanker, Alexandre Mouradian, along with a pan-European team led by biotech expert Rodolphe Besserve and a prestigious international Scientific Advisory Board who supports the company in all its strategic and investment decisions.
Our common goal: think outside the box !
Creating a unique ecosystem
of ideation and cross-fertilization
eureKARE not only supports translational research by creating and financing new companies through its biotech start-up studios but also invests in European biotech companies at a later stage of development
Focus on two cutting-edge research fields
eureKABIOME Our Biotech Studio dedicated to the microbiome. We believe the microbiome is the key to unlocking the understanding and treatment of many diseases. Recent scientific advances and major funding rounds underline its huge potential.
eureKASYNBIO Our Biotech Studio dedicated to synthetic biology. Synthetic biology is entering a new era thanks to the emergence of disruptive technologies that will impact many fields including bioproduction, agriculture, data storage and human health.
News & Insights
-MaaT Pharma launches its initial public offering on the regulated market of Euronext in Paris -eureKARE to be cornerstone investor of the IPO of Maat Pharma
-Agenda for the event, featuring leaders in synthetic biology, now released -Virtual event on 10 November 2021; Registration is open -eureKAWARDS winner will be announced at …
-eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS -Dr Iordanis Arzimanoglou, European Innovation Council Programme Manager for Health and Biotechnology, …
-Potter Clarkson and ERS Genomics to join forces with eureKARE on the eureKAWARDS -Potter Clarkson to offer the winner a Kick-StartiP consultancy -ERS Genomics to provide the …
Stellate Therapeutics Inc. (“the Company”, “Stellate”), a global biotechnology company developing disease-modifying therapies based on molecules derived from the microbiome to treat neurological conditions, is …